Fine needle aspiration cytology in advanced pediatric tumors

dc.contributor.authorShakoor, K.A.
dc.date.accessioned2013-06-21T20:12:55Z
dc.date.accessioned2017-10-16T12:26:20Z
dc.date.available2013-06-21T20:12:55Z
dc.date.available2017-10-16T12:26:20Z
dc.date.issued1989
dc.description.abstractEighty-one children with clinically suspected malignant tumors were subjected to percutaneous fine needle aspiration cytology (FNAC) at the Pathology Department of the National Institute of Child Health, Jinnah Postgraduate Medical Centre, Karachi, from August 1986 through July 1987. There were 47 malignant diagnoses including lymphoma, neuroblastoma, nephroblastoma, Ewing's sarcoma, and leukemia. Histological findings confirmed the FNAC diagnoses in 36 cases in which a subsequent incisional biopsy or surgically removed specimen was available. FNAC results were confirmed in all benign cases. In 10 advanced cases of NonHodgkin's lymphoma, surgery was not possible because of marked malnourishment. One false negative and no false positive result was encountered. Forty-eight were females and thirty-three males. FNAC can be a quick, effective, and inexpensive alternative to open biopsy, particularly in advanced cases of malignancy in undernourished children where anesthesia and immediate surgery are contraindicated.en_US
dc.identifier.citationShakoor, K. A. (1989). Fine needle aspiration cytology in advanced pediatric tumors. Pediatric Pathology, 9(6), 713-718en_US
dc.identifier.issn02770938
dc.identifier.urihttp://197.255.68.203/handle/123456789/3948
dc.language.isoenen_US
dc.publisherPadiatric Pathologyen_US
dc.subjectine needle aspiration cytology, NonHodgkin's lymphoma, pediatric tumorsen_US
dc.titleFine needle aspiration cytology in advanced pediatric tumorsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description:
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: